Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 5
2011 2
2012 3
2013 6
2014 4
2015 1
2016 3
2017 7
2018 8
2019 9
2020 4
2021 7
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H. Hatemi G, et al. Among authors: leccese p. Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6. Ann Rheum Dis. 2018. PMID: 29625968
Behcet's syndrome in nonendemic regions.
Leccese P, Yazici Y, Olivieri I. Leccese P, et al. Curr Opin Rheumatol. 2017 Jan;29(1):12-16. doi: 10.1097/BOR.0000000000000349. Curr Opin Rheumatol. 2017. PMID: 27684358 Review.
Behçet's Disease: An Overview of Etiopathogenesis.
Leccese P, Alpsoy E. Leccese P, et al. Front Immunol. 2019 May 10;10:1067. doi: 10.3389/fimmu.2019.01067. eCollection 2019. Front Immunol. 2019. PMID: 31134098 Free PMC article. Review.
Golimumab for the treatment of axial spondyloarthritis.
Palazzi C, D'angelo S, Gilio M, Leccese P, Padula A, Olivieri I. Palazzi C, et al. Among authors: leccese p. Expert Opin Biol Ther. 2017 Jan;17(1):129-133. doi: 10.1080/14712598.2017.1256387. Epub 2016 Nov 9. Expert Opin Biol Ther. 2017. PMID: 27817204 Review.
Pharmacological therapy of spondyloarthritis.
Palazzi C, D'Angelo S, Gilio M, Leccese P, Padula A, Olivieri I. Palazzi C, et al. Among authors: leccese p. Expert Opin Pharmacother. 2015;16(10):1495-504. doi: 10.1517/14656566.2015.1052744. Epub 2015 Jun 14. Expert Opin Pharmacother. 2015. PMID: 26073668 Review.
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission.
Giacomelli R, Caporali R, Ciccia F, Colafrancesco S, Dagna L, Govoni M, Iannone F, Leccese P, Montecucco C, Pappagallo G, Pistone G, Priori R, Ruscitti P, Sfriso P, Cantarini L; Expert Panel. Giacomelli R, et al. Among authors: leccese p. Autoimmun Rev. 2023 Dec;22(12):103400. doi: 10.1016/j.autrev.2023.103400. Epub 2023 Jul 22. Autoimmun Rev. 2023. PMID: 37482365 Review.
Late-onset spondyloarthritis: subset that should not be forgotten.
Olivieri I, D'Angelo S, Palazzi C, Leccese P, Padula A. Olivieri I, et al. Among authors: leccese p. J Rheumatol. 2012 Jun;39(6):1110-2. doi: 10.3899/jrheum.120184. Epub 2012 May 15. J Rheumatol. 2012. PMID: 22589252 No abstract available.
Spondyloarthritis with onset after age 45.
Olivieri I, D'Angelo S, Padula A, Leccese P, Palazzi C. Olivieri I, et al. Among authors: leccese p. Curr Rheumatol Rep. 2013 Dec;15(12):374. doi: 10.1007/s11926-013-0374-7. Curr Rheumatol Rep. 2013. PMID: 24170254 Review.
61 results